Benzinga | Aug 5, 2021 04:51PM EDT

Iovance Biotherapeutics Q2 EPS $(0.53) Misses $(0.51) Estimate

Iovance Biotherapeutics (NASDAQ:IOVA) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.51) by 3.92 percent. This is a 12.77 percent decrease over losses of $(0.47) per share from the same period last year.